دورية أكاديمية
Does repetitive dilatation and curettage or hysteroscopic biopsy in patients treated with progestins for endometrial hyperplasia or carcinoma affect subsequent fetomaternal outcomes? A population-based study using the National Health Insurance Research Database of Taiwan.
| العنوان: | Does repetitive dilatation and curettage or hysteroscopic biopsy in patients treated with progestins for endometrial hyperplasia or carcinoma affect subsequent fetomaternal outcomes? A population-based study using the National Health Insurance Research Database of Taiwan. |
|---|---|
| المؤلفون: | Lin H; Department of Obstetrics and Gynecology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan., Chen WH; Department of Obstetrics and Gynecology, Chiayi Chang Gung Memorial Hospital, Chiayi, Taiwan., Chen CY; Department of Obstetrics and Gynecology, Chiayi Chang Gung Memorial Hospital, Chiayi, Taiwan., Yang YH; Department of Traditional Chinese Medicine, Chiayi Chang Gung Memorial Hospital, Chiayi, Taiwan.; School of Traditional Chinese Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan.; Health Information and Epidemiology Laboratory, Chang Gung Memorial Hospital, Chiayi, Taiwan., Lee CP; Health Information and Epidemiology Laboratory, Chang Gung Memorial Hospital, Chiayi, Taiwan., Chen KJ; Health Information and Epidemiology Laboratory, Chang Gung Memorial Hospital, Chiayi, Taiwan., Ou YC; Department of Obstetrics and Gynecology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.; Department of Obstetrics and Gynecology, Chiayi Chang Gung Memorial Hospital, Chiayi, Taiwan. |
| المصدر: | International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics [Int J Gynaecol Obstet] 2024 Feb; Vol. 164 (2), pp. 605-612. Date of Electronic Publication: 2023 Sep 18. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Wiley Country of Publication: United States NLM ID: 0210174 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-3479 (Electronic) Linking ISSN: 00207292 NLM ISO Abbreviation: Int J Gynaecol Obstet Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 2017- : Malden, MA : Wiley Original Publication: [New York, NY] Hoeber Medical Division, Harper & Row, [c1969- |
| مواضيع طبية MeSH: | Endometrial Hyperplasia*/pathology , Premature Birth*/epidemiology , Carcinoma* , Endometrial Neoplasms*/pathology, Infant, Newborn ; Humans ; Female ; Progestins ; Taiwan ; Dilatation and Curettage ; Biopsy |
| مستخلص: | Objective: To investigate the impact of repeated dilatation and curettage or hysteroscopic biopsy on fetomaternal outcomes in patients receiving progestin treatment for endometrial hyperplasia or early-stage carcinoma. Method: This was a population-based study using the Taiwan National Health Insurance Research Database between 2009 and 2017 of women who gave birth and had a history of endometrial hyperplasia and early-stage carcinoma treated with progestins. Logistic regression analysis was used to estimate adjusted odds ratios (aORs) with 95% confidence intervals (CIs) reflecting the association between repeated procedures and fetomaternal outcomes. Results: A total of 6956 women with 8690 deliveries were identified. Compared with those who had two or fewer procedures, women who received more than two procedures had a significantly higher risk for cervical insufficiency (aOR, 5.09 [95 CI, 2.31-11.24]). Furthermore, women who had more than two procedures were prone to have adverse neonatal outcomes, including Apgar score < 7 at 1 min (aOR, 1.97 [95% CI, 1.13-3.43]) and 5 min (aOR, 3.11 [95% CI, 1.33-7.23]) and preterm delivery <32 weeks (aOR, 2.86 [95% CI, 1.50-5.45]). Conclusion: Undergoing more than two procedures was associated with subsequent maternal cervical insufficiency, preterm delivery <32 weeks, and low neonatal Apgar score. Health care providers should be aware of the potential risks and balance the benefits and harms of repeated procedures. (© 2023 International Federation of Gynecology and Obstetrics.) |
| References: | Yuk JS. The incidence rates of endometrial hyperplasia and endometrial cancer: a four-year population-based study. Peer J. 2016;4:e2374. Reed SD, Newton KM, Clinton WL, et al. Incidence of endometrial hyperplasia. Am J Obstet Gynecol. 2009;200(678):e1-e6. Emons G, Beckmann MW, Schmidt D, Mallmann P, Uterus commission of the Gynecological Oncology Working Group (AGO). New WHO classification of endometrial hyperplasias. Geburtshilfe Frauenheilkd. 2015;75:135-136. Management of endometrial hyperplasia. Green-top guideline No. 67. Royal College of Obstetricians and Gynaecologists/British Society for Gynaecological Endoscopy. 2016. Kim MK, Seong SJ, Park DC, Hong JH, Roh JW, Kang SB. Comparison of diagnostic accuracy between endometrial curettage and aspiration biopsy in patients treated with progestin for endometrial hyperplasia: a Korean Gynecologic Oncology Group study. J Gynecol Oncol. 2020;31:e51. Hooker A, Fraenk D, Brölmann H, Huirne J. Prevalence of intrauterine adhesions after termination of pregnancy: a systematic review. Eur J Contracept Reprod Health Care. 2016;21:329-335. Hooker AB, de Leeuw RA, Twisk JWR, Brölmann HAM, Huirne JAF. Reproductive performance of women with and without intrauterine adhesions following recurrent dilatation and curettage for miscarriage: long-term follow-up of a randomized controlled trial. Hum Reprod. 2021;36:70-81. McCarthy FP, Khashan AS, North RA, et al. Pregnancy loss managed by cervical dilatation and curettage increases the risk of spontaneous preterm birth. Hum Reprod. 2013;28:3197-3206. Field K, Murphy DJ. Perinatal outcomes in a subsequent pregnancy among women who have experienced recurrent miscarriage: a retrospective cohort study. Hum Reprod. 2015;30:1239-1245. Klemetti R, Gissler M, Niinimäki M, Hemminki E. Birth outcomes after induced abortion: a nationwide register-based study of first births in Finland. Hum Reprod. 2012;27:3315-3320. Lemmers M, Verschoor MA, Hooker AB, et al. Dilatation and curettage increases the risk of subsequent preterm birth: a systematic review and meta-analysis. Hum Reprod. 2016;31:34-45. Chawanpaiboon S, Vogel JP, Moller AB, et al. Global, regional, and national estimates of levels of preterm birth in 2014: a systematic review and modelling analysis. Lancet Glob Health. 2019;7:e37-e46. Boelig RC, Villani M, Jiang E, Orzechowski KM, Berghella V. Prior uterine evacuation and the risk of short cervical length: a retrospective cohort study. J Ultrasound Med. 2018;37:1763-1769. Anum EA, Brown HL, Strauss JF 3rd. Health disparities in risk for cervical insufficiency. Hum Reprod. 2010;25:2894-2900. Gökçe A, Şükür YE, Özmen B, et al. The association between operative hysteroscopy prior to assisted reproductive technology and cervical insufficiency in second trimester. Arch Gynecol Obstet. 2021;303:1347-1352. Iqbal SMA, Deska-Gauthier D, Kreplak L. Assessing collagen fibrils molecular damage after a single stretch-release cycle. Soft Matter. 2019;15:6237-6246. Cordeiro Mitchell CN, Hunkler KF, Maher JY, et al. Conservatively treated endometrial intraepithelial neoplasia/cancer: risk of intrauterine synechiae. J Gynecol Obstet Hum Reprod. 2021;50:101930. Inoue O, Hamatani T, Susumu N, et al. Factors affecting pregnancy outcomes in young women treated with fertility-preserving therapy for well-differentiated endometrial cancer or atypical endometrial hyperplasia. Reprod Biol Endocrinol. 2016;14:2. Beuker JM, Erwich JJ, Khong TY. Is endomyometrial injury during termination of pregnancy or curettage following miscarriage the precursor to placenta accreta? J Clin Pathol. 2005;58:273-275. Carusi DA. The placenta accreta spectrum: epidemiology and risk factors. Clin Obstet Gynecol. 2018;61:733-742. Hsu CY, Lo JC, Chang JH, Chen CP, Yu S, Huang FY. Cesarean births in Taiwan. Int J Gynaecol Obstet. 2007;96:57-61. Department of Household Registration, Ministry of the Interior. 2021 Demographic Fact Book R.O.C. http://www.cedaw.org.tw/en/en-global/news/detail/245. Sakai Y, Ono M, Iizuka T, et al. Embryo transfer associated with hormone replacement therapy cycles using assisted reproductive technology increases placenta accreta spectrum. J Obstet Gynaecol Res. 2019;45:2394-2399. Imafuku H, Tanimura K, Shi Y, Uchida A, Deguchi M, Terai Y. Clinical factors associated with a placenta accreta spectrum. Placenta. 2021;112:180-184. |
| معلومات مُعتمدة: | CLRPG6L0081 Chiayi Chang Gung Memorial Hospital, Taiwan |
| فهرسة مساهمة: | Keywords: dilatation and curettage; endometrial carcinoma; endometrial hyperplasia; fetomaternal outcomes; progestin treatment |
| المشرفين على المادة: | 0 (Progestins) |
| تواريخ الأحداث: | Date Created: 20230919 Date Completed: 20240115 Latest Revision: 20240115 |
| رمز التحديث: | 20240115 |
| DOI: | 10.1002/ijgo.15108 |
| PMID: | 37723982 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1879-3479 |
|---|---|
| DOI: | 10.1002/ijgo.15108 |